About SVB Securities
SVB Securities is an investment bank founded in 1995. It is primarily based in Boston, United States. As of Apr 2026, SVB Securities has facilitated 214 deals, comprising 103 M&A deals and 111 funding rounds. It primarily facilitates Business Acquisition and Post IPO deals for United States and Canada based companies. The deals facilitated are spread across a wide range of sectors from Life Sciences to Healthcare. Most recently, it facilitated the $***** Series C round of Upperline Health on May 09, 2023 and the acquisition of ELIOS Vision by Bausch & Lomb on Dec 11, 2024. Apart from facilitating deals, SVB Securities has also invested in 20 companies.
Key Metrics
Founded Year
1995
Location
Boston, United States
No. of Deals facilitated
214
Top Deal Types
Business Acquisition, Post IPO
Top Locations of Deals
Top Sectors of Deals
Funding Rounds Facilitated
M&A Facilitated
Recent Funding Deals facilitated by SVB Securities
SVB Securities has facilitated a total of 111 funding deals including Series C deals. The latest round that they facilitated was on May 09, 2023 for Upperline Health in their Series C round of $*****.Their most notable funding round deals include a $***** Post IPO round of Gilead.Here is the list of recent funding rounds facilitated by SVB Securities:
Date | Company | Round Name | Amount | Investors |
|---|---|---|---|---|
May 09, 2023 | Series C | 1343 | and 2 more | |
May 05, 2023 | Post IPO | 5151 | - | |
Apr 13, 2023 | Post IPO | 9554 | ||
Mar 28, 2023 | Post IPO | 9039 |
Recent M&A Deals facilitated by SVB Securities
The latest M&A that they facilitated was on Dec 11, 2024 where ELIOS Vision was acquired by Bausch & Lomb.Their most notable M&A deals include acquisition of Dermswohio by Sheridan.Here is the list of recent M&A deals facilitated by SVB Securities:
Date | Company | Amount | Acquirers | Co Facilitators |
|---|---|---|---|---|
Dec 11, 2024 | - | |||
Dec 22, 2023 | - | and 1 more | ||
Nov 22, 2023 | - | and 1 more | ||
Aug 10, 2023 | - |
Team profile of SVB Securities
SVB Securities has a team of 8 members including 5 Partners and 1 Principal located in United States. SVB Securities' team does not sit on the board of any company as of now.Here is a list of all team members in SVB Securities:
Name | Designation | Location | Contact Details |
|---|---|---|---|
Partner | Boston | ||
Partner | New York City | ||
Partner | Boston | ||
Partner | New York City | ||
Partner | - | ||
Principal | New York City |
SVB Securities News
•
NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded WarrantsGlobeNewswire•Dec 12, 2024•NewAmsterdam Pharma, Jefferies, Goldman Sachs, SVB Securities and 3 others
•
NewAmsterdam Pharma Announces Commencement of $300 Million Public Offering of Ordinary Shares and Pre-Funded WarrantsGlobeNewswire•Dec 11, 2024•NewAmsterdam Pharma, Jefferies, Goldman Sachs, Leerink Partners and 4 others
•
Rocket Pharmaceuticals plans $150 million stock offeringInvesting•Dec 11, 2024•Rocket Pharma, Morgan Stanley, SVB Securities, Cantor Fitzgerald and 2 others
•
MoonLake Immunotherapeutics Announces Proposed Underwritten Public OfferingGlobeNewswire•Jun 27, 2023•MoonLake, SVB Securities, Guggenheim Partners, Cantor Ventures and 1 other
•
•
SVB Financial Group Sells SVB Securities to Management Team Backed by Baupost GroupMonitordaily•Jun 19, 2023•SVB Securities, The Baupost Group, SVB
•
•
SVB Securities to Be Acquired in Management BuyoutThe Wall Street Journal•Jun 19, 2023•SVB Securities, SVB, The Baupost Group
•
Vox Announces Marketed Offering Of Common SharesNXTmine•Jun 13, 2023•Vox, Maxim Group, BMO, Disc Medicine and 4 others
•
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire•Jun 13, 2023•Disc Medicine, Morgan Stanley, SVB Securities, Stifel and 1 other
